NZ Cancer Control Agency’s medicines report deeply disappointing

The Breast Cancer Aotearoa Coalition (BCAC) says it is deeply disappointed by a report on cancer medicines released by New Zealand’s Cancer Control Agency, the Te Aho o Te Kahu.

“We’re stunned to see that Te Aho o Te Kahu has identified only one breast cancer drug as needed but not funded in New Zealand. This is completely out of step with Australia and other countries and disregard international guidelines on breast cancer treatment.…

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

• All the news that moves the needle in pharma and biotech.
• Exclusive features, podcasts, interviews, data analyzes and commentary from our global network of life sciences reporters.
• Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

• Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
• Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
• Daily roundup of key events in pharma and biotech.
• Monthly in-depth briefings on Boardroom appointments and M&A news.
• Choose from a cost-effective annual package or a flexible monthly subscription.


Leave a Comment